Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Hormone replacement therapy is associated with decreased survival in women with lung cancer.

Ganti AK, Sahmoun AE, Panwalkar AW, Tendulkar KK, Potti A.

J Clin Oncol. 2006 Jan 1;24(1):59-63. Epub 2005 Nov 28.

PMID:
16314616
2.

Hormone replacement therapy and survival in lung cancer in postmenopausal women in a rural population.

Huang B, Carloss H, Wyatt SW, Riley E.

Cancer. 2009 Sep 15;115(18):4167-75. doi: 10.1002/cncr.24475.

3.

Are smoking-associated cancers prevented or postponed in women using hormone replacement therapy?

Olsson H, Bladström A, Ingvar C.

Obstet Gynecol. 2003 Sep;102(3):565-70.

PMID:
12962944
4.

Hormone replacement therapy as a risk factor for non-small cell lung cancer: results of a case-control study.

Ramnath N, Menezes RJ, Loewen G, Dua P, Eid F, Alkhaddo J, Paganelli G, Natarajan N, Reid ME.

Oncology. 2007;73(5-6):305-10. doi: 10.1159/000134238. Epub 2008 May 21.

PMID:
18493157
5.

Lung cancer death rates in lifelong nonsmokers.

Thun MJ, Henley SJ, Burns D, Jemal A, Shanks TG, Calle EE.

J Natl Cancer Inst. 2006 May 17;98(10):691-9.

PMID:
16705123
6.

Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women.

Schwartz AG, Wenzlaff AS, Prysak GM, Murphy V, Cote ML, Brooks SC, Skafar DF, Lonardo F.

J Clin Oncol. 2007 Dec 20;25(36):5785-92.

PMID:
18089876
7.

Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy.

Schuetz F, Diel IJ, Pueschel M, von Holst T, Solomayer EF, Lange S, Sinn P, Bastert G, Sohn C.

Am J Obstet Gynecol. 2007 Apr;196(4):342.e1-9.

PMID:
17403414
8.

Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms.

Sestak I, Kealy R, Edwards R, Forbes J, Cuzick J.

J Clin Oncol. 2006 Aug 20;24(24):3991-6.

PMID:
16921052
9.

Determinants of hormone replacement therapy duration among postmenopausal women with intact uteri.

Gavin NI, Thorp JM, Ohsfeldt RL.

Menopause. 2001 Sep-Oct;8(5):377-83.

PMID:
11528366
10.

Hormone replacement therapy is associated with improved survival in women with advanced heart failure.

Lindenfeld J, Ghali JK, Krause-Steinrauf HJ, Khan S, Adams K, Goldman S, Peberdy MA, Yancy C, Thaneemit-Chen S, Larsen RL, Young J, Lowes B, Rosenberg YD; BEST Investigators.

J Am Coll Cardiol. 2003 Oct 1;42(7):1238-45.

11.

Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women.

Shlipak MG, Angeja BG, Go AS, Frederick PD, Canto JG, Grady D.

Circulation. 2001 Nov 6;104(19):2300-4.

12.

The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women.

Alexandersen P, Tankó LB, Bagger YZ, Qin G, Christiansen C.

Climacteric. 2006 Apr;9(2):108-18.

PMID:
16698657
14.

Hormone replacement therapy after invasive ovarian serous cystadenocarcinoma treatment: the effect on survival.

Ursic-Vrscaj M, Bebar S, Zakelj MP.

Menopause. 2001 Jan-Feb;8(1):70-5.

PMID:
11201519
15.

Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.

Windler E, Zyriax BC, Eidenmüller B, Boeing H.

Maturitas. 2007 Jul 20;57(3):239-46. Epub 2007 Feb 9.

PMID:
17292571
16.

Breast cancer in postmenopausal women with and without hormone replacement therapy: preliminary results of the MISSION study.

Espié M, Mares P, de Reilhac P, Chevallier T, Daurès JP.

Gynecol Endocrinol. 2006 Aug;22(8):423-31.

PMID:
17012103
17.

Type and duration of exogenous hormone use affects breast cancer histology.

Kumar AS, Cureton E, Shim V, Sakata T, Moore DH, Benz CC, Esserman LJ, Hwang ES.

Ann Surg Oncol. 2007 Feb;14(2):695-703. Epub 2006 Nov 14.

PMID:
17103262
18.

Smoking cessation before diagnosis and survival in early stage non-small cell lung cancer patients.

Zhou W, Heist RS, Liu G, Park S, Neuberg DS, Asomaning K, Wain JC, Lynch TJ, Christiani DC.

Lung Cancer. 2006 Sep;53(3):375-80. Epub 2006 Jun 30.

PMID:
16814423
19.

Persistence with oral and transdermal hormone replacement therapy and hospitalisation for cardiovascular outcomes.

Corrao G, Zambon A, Nicotra F, Fornari C, La Vecchia C, Mezzanzanica M, Nappi RE, Merlino L, Cesana G.

Maturitas. 2007 Jul 20;57(3):315-24. Epub 2007 May 7.

PMID:
17485182
20.

Postmenopausal hormone therapy and lung cancer risk in the cancer prevention study II nutrition cohort.

Rodriguez C, Spencer Feigelson H, Deka A, Patel AV, Jacobs EJ, Thun MJ, Calle EE.

Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):655-60. doi: 10.1158/1055-9965.EPI-07-2683.

Supplemental Content

Support Center